MedTrace Logo

Early Closure of Temporary Ileostomy

NCT01287637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2016-01-20

No results posted yet for this study

Summary

The study is being conducted as a prospective randomized controlled multicenter study of patients with a temporary ileostomy due to rectal cancer. The study will be conducted in hospitals in Denmark and Sweden under the framework of the Scandinavian Surgical Outcomes Group (www.ssorg.net).

The study investigates the effect of reversing a temporary ileostomy after 8-13 days instead of later reversal more than 12 weeks after surgery.

Conditions

Interventions

PROCEDURE

Early reversal of temporary ileostomy

Temporary ileostomy is reversed 8-13 days after the primary surgery

PROCEDURE

Standard reversal of temporary ileostomy

Patients in the control group will have the ileostomy reversed according to standard treatment, which is 12-26 weeks after primary operation

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Jacob Rosenberg, Professor · Herlev Hospital, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01287637 on ClinicalTrials.gov